Clinical Trial Supplies Market by End-user, Type and Geography - Forecast and Analysis 2023 - 2027

Clinical Trial Supplies Market Forecast 2023-2027

The global clinical trial supplies market size is estimated to grow by USD 1.19 billion at a CAGR of 8.48% between 2022 and 2027.  There is a growing need for clinical research to develop new drugs, biological products, and medical devices to meet the need for the prevention and treatment of chronic diseases. Many private drugmakers and biologics support these clinical trials with research and funds. Furthermore, as clinical trials are conducted on different temperature-sensitive pharmaceutical and biological ingredients, the demand for cold chain storage is increasing globally. Medical device clinical trials also require an optimized supply chain management system. Therefore, government initiatives to develop GCPs for drugs, biologics, and medical devices are expected to drive the growth of the global market during the forecast period.

It also includes an in-depth analysis of drivers, trends, and challenges. Our report examines historic data from 2017 to 2021 besides analyzing the current market scenario.

What will be the Size of the Clinical Trial Supplies Market During the Forecast Period?

To learn more about this report, Request Free Sample

Market Segmentation by End-user, Type, and Geography Analysis

Technavio has segmented the market into End-user, Type, and Geography

• The end-user segment includes the pharmaceutical industry, biologics industry, and medical device industry
• the type segment includes Phase iii, Phase ii, Phase iv and BE/BA studies, and Phase i
• The geography segment includes key regions such as North America, Europe, Asia, and Rest of World (ROW)

End-user Analysis: 

pharmaceutical industry

The market share growth by the pharmaceutical industry segment will be significant during the forecast period. Drug discovery and bringing a new drug to market are complex processes and require clinical trials to test the safety, effectiveness, and performance of new drugs. In addition, stringent regulations developed by the FDA to ensure the safety and effectiveness of new and personalized drugs are increasing the need for clinical trials for pharmaceuticals.

Get a glance at the market contribution of various segments View a PDF Sample

The pharmaceutical industry segment was valued at USD 855.76 million in 2017. The need to develop new drugs and introduce new generic and brand-name drugs in the market is constantly increasing due to the proliferation of epidemic diseases and chronic diseases. Furthermore, there is a growing need for clinical trial supplies from the pharmaceutical industry to provide logistics and warehousing facilities for manufacturers and CROs. As a result, clinical trial supplies suppliers have more opportunities to provide services such as logistics and supply chain management, helping to increase the share of the pharmaceutical industry in the market during the forecast period. 

Type Segment Analysis:  

Phase III

The high demand for supplies for phase III clinical trials is an important step in the drug development process. These trials have larger numbers of participants, often span multiple locations and countries, and are designed to assess a drug's safety, effectiveness, and overall benefit-risk profile. Phase III trials are longer than previous phases, sometimes lasting months or even years. Furthermore, sufficient supplies such as biological samples, investigational drugs, and kits are required to perform ongoing safety assessments, which increases the need for clinical trial supplies, which in turn will fuel the growth of the global market in focus during the forecast period. 

Phase II

Phase II clinical trials are an important step in drug development, as they aim to further evaluate the safety and effectiveness of an experimental drug or treatment on a large group of patients. Phase II trials often explore different dosages and treatment regimens to determine the most effective and safest dosage for further development. This requires a sufficient supply of study products for each dose level. Phase II trials provide essential safety and efficacy data that will be used to determine whether the drug will move to a Phase III trial. Clinical trial supply is essential to generate reliable data that will drive the growth of the market during the forecast period.

Regional Analysis

For more insights about the market share of various regions View PDF Sample now!

North America is estimated to contribute 36% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that will shape the market during the forecast period. The prevalence of chronic diseases is increasing, the number of clinical trials is increasing, and the number of life science research activities is increasing in the US and Canada. The US and Canada represent the largest continental pharmaceutical markets in the world. Pharmaceutical companies are one of the major customers for clinical trial supplies due to the large number of clinical trials conducted to validate their new drug discoveries and get them out in the market.

Furthermore, the lack of divergence between regional regulatory policies and the FDA is a key factor driving the increased number of clinical trials in this region. Besides, the growing demand for outsourcing clinical trials is also boosting the need for clinical trial services, including logistics, warehousing, and the safety of clinical trial supplies. Thus, such factors will drive the growth of the market in this region during the forecast period. 

Buy Now Full Report and Discover More

Key Clinical Trial Supplies Market Players 

Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market. The report also includes detailed analyses of the competitive landscape of the market and information about 20 market companies, including:

Catalent Inc.: The company offers clinical trial supplies services such as package material management, QC test, GMP release, and product delivery.

• Avantor Inc.
• Bionical Emas Group
• Bushu Pharmaceuticals Ltd.
• Clinical Services International Ltd.
• Clinigen Group Plc
• Deutsche Bahn AG
• Emsere B.V
• GNH India Pharmaceuticals Ltd.
• International Bonded Couriers Inc.
• Nuvisan GmbH
• Obvio Health USA Inc.
• Parexel International Corp.
• PHOENIX Pharmahandel GmbH and Co KG
• Piramal Enterprises Ltd.
• Thermo Fisher Scientific Inc.
• Vertical Pharma Resources Ltd.
• Ancillare LP
• PCI Pharma Services
• Precision Medicine Group LLC

Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

Market Dynamics and Customer Landscape

There are multiple factors influencing market growth. Our researchers analyzed the data with 2022 as the base year, along with the key drivers, trends, and challenges. 

Key Market Drivers

The growth of the biopharmaceutical industry is one of the key factors driving the growth of the market. The dynamics of the biopharmaceutical industry are changing as the pharmaceutical industry looks to the biopharmaceutical industry to discover new drugs and biosimilars introduced to the market by new global participants. Biopharmaceuticals have reduced the number of deaths from cancer and HIV/AIDS in the last few years, which has led to an increase in the use of biopharmaceuticals in the global market.

Moreover, the significant expansion of the global biopharmaceutical market has led to the development of many other industries, such as contract research, contract manufacturing, consumables, and pharmaceuticals. as well as clinical trials. The research and production of drugs and biologics involves clinical trials to ensure a product's safety, effectiveness, and minimal side effects. As a result, the growing biopharmaceutical industry leads to the growth of the clinical trials market during the forecast period. 

Significant Market Trends

An increase in studies focusing on the pharmaceutical industry is one of the primary trends in the market. Increasing clinical research into several types of cancer has contributed to a greater emphasis on personalized medicine as pharmaceutical companies seek to invest in the latest market trends. Government funding is also contributing to the growth of personalized medicine. Precision medicine requires different ways to test interventions. Researchers need to probe a multitude of factors, such as genetics and environmental factors, that determine a person's response to treatment.

Furthermore, due to the substantial growth of drug-targeted studies, the need for further clinical trials has increased in the last few years. Newly approved drugs and applied drugs must be safe, targeted, and have long-term effectiveness, as guaranteed by clinical trial services. As a result, the growing number of clinical trial services to ensure the safety of new drugs has fueled the growth and development of clinical trial supplies, which will drive growth. market during the forecast period. 

Major Market Challenges

The high cost of clinical trials is a challenge that affects market growth. Clinical trials have changed over the years, and as a result, there are growing concerns about the growing cost of clinical trials. Another challenge is patient recruitment, and studies by the Centers for Disease Control and Prevention (CDC) have shown that of all clinical trials registered in the US, about 48-50% of Clinical trials were delayed due to problems during implementation, patient recruitment or some trials could not find patient recruitment. In addition, increasing awareness of the clinical trial process will lead to increased participation of recruited patients in the trial. Pharmaceutical companies should emphasize patient education rather than persuasion.

Furthermore, the cost of developing and manufacturing a vaccine depends on the type of vaccine, the level of innovation, the target disease, and the regulatory agency. The total cost of developing and manufacturing a vaccine could exceed USD 50 million. Each phase of a vaccine clinical trial has a different cost structure. For example, a Phase I clinical trial development can range from USD 2 million for a convertible product to USD 60 million for an innovative product, with an average cost of USD 12 million for essential chemicals, production, and control (CMC) essentials. Therefore, increasing clinical trial costs may hinder the growth of the market during the forecast period. 

Buy Now Full Report and Discover More

Key Market Customer Landscape

The market report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.

Global Market Customer Landscape

Segment Overview

The market report forecasts market growth by revenue at global, regional & country levels and provides an analysis of the latest trends and growth opportunities from 2017 to 2027. 

• End-user Outlook 
  • Pharmaceutical industry
  • Biologics industry
  • Medical device industry

• Type Outlook 
  • Phase III
  • Phase II
  • Phase IV and BE/BA studies
  • Phase I

• Region Outlook 
  • North America
    • The U.S.
    • Canada
  • Europe
    • The U.K.
    • Germany
    • France
    • Rest of Europe
  • Asia
    • China
    • India
  • Rest of the World (ROW)
    • Brazil 
    • Australia
    •  Argentina

Market Analyst Overview

The market is pivotal in facilitating the advancement of medical research, particularly in areas like oncology and rare diseases. With the rise of biological drugs and biologics, the demand for biological trial supplies and nanoparticle-based drug delivery systems is escalating. Cold chain capabilities and cold storage distribution play a critical role in maintaining the integrity of blood products and vaccines during transportation. However, challenges like the high cost of drug development and failure of clinical trials underscore the importance of regulatory support and investment in drug development. Technological advancements are driving innovations in electronic records and signatures, streamlining processes, and ensuring good clinical practices are followed across clinical research activities. Amidst globalization, collaboration among contract research organizations (CROs) and clinical research organizations is crucial in overcoming hurdles and meeting the diverse needs of key stakeholders in the pharmaceutical industry.

In the realm of medical research, the market plays a pivotal role in facilitating the development and approval of novel pharmaceutical drugs, including biologics & biosimilar drugs. Ensuring the integrity and efficacy of these supplies requires meticulous attention to detail, including cold chain distribution and storage and distribution to maintain potency. Challenges such as hindrance in drug approval and limitations in clinical trials necessitate close adherence to FDA regulations and protection of human subjects. Moreover, with the decentralization of clinical trials, logistics become even more crucial, emphasizing the need for efficient healthcare logistics and skilled labourers. Collaboration among CROs and industrial collaborations drives innovation in manufacturing processes and packaging, advancing the novel drug development process while ensuring labeling compliance and regulatory support.

Clinical Trial Supplies Market Scope
Report Coverage	Details
Page number	162
Base year	2022
Historic period	2017-2021
Forecast period	2023-2027
Growth momentum & CAGR	Accelerate at a CAGR of 8.48%
Market growth 2023-2027	USD 1.19 billion
Market structure	Fragmented
YoY growth 2022-2023(%)	7.42
Regional analysis	North America, Europe, Asia, and Rest of World (ROW)
Performing market contribution	North America at 36%
Key countries	US, UK, Germany, China, and Japan
Competitive landscape	Leading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks
Key companies profiled	Avantor Inc., Bionical Emas Group, Bushu Pharmaceuticals Ltd., Catalent Inc., Clinical Services International Ltd., Clinigen Group Plc, Deutsche Bahn AG, Emsere B.V, GNH India Pharmaceuticals Ltd., International Bonded Couriers Inc., Nuvisan GmbH, Obvio Health USA Inc., Parexel International Corp., PHOENIX Pharmahandel GmbH and Co KG, Piramal Enterprises Ltd., Thermo Fisher Scientific Inc., Vertical Pharma Resources Ltd., Ancillare LP, PCI Pharma Services, and Precision Medicine Group LLC
Market dynamics	Parent market analysis, Market forecasting, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for the forecast period.
Customization purview	If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

View Sample PDF at your Fingertips

What are the Key Data Covered in this Market Research Report?

• CAGR of the market during the forecast period
• Detailed information on factors that will drive the market growth and forecasting of the market between 2023 and 2027
• Precise estimation of the size of the market size and its contribution to the parent market
• Accurate predictions about upcoming market trends and analysis and changes in consumer behavior
• Growth of the market industry across Europe, North America, APAC, South America, and Middle East and Africa
• Thorough market growth analysis of the market’s competitive landscape and detailed information about vendors
• Comprehensive market analysis and report on the factors that will challenge the market research and growth of market companies

We can help! Our analysts can customize this market research report to meet your requirements. Get in touch